A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation-Reference-Cited by-同舟云学术

A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation

Published:2015-01-28 Issue:1 Volume:20 Page:
ISSN:2047-783X
Container-title:European Journal of Medical Research
language:en
Short-container-title:Eur J Med Res

Author:

Khawar Babar,Abbasi Muddasir Hassan,Sheikh Nadeem

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40001-015-0083-y.pdf

Reference80 articles.

1. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–42.

2. Dinarello CA. Proinflammatory cytokines. Chest J. 2000;118:503–8.

3. Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992;148:597–603.

4. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006;1:581–5.

5. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNF-alpha. Immunity. 2005;22:131–42.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriatic arthritis subtypes are phenocopied in humanized mice;JCI Insight;2024-07-02

2. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle;Clinical and Translational Oncology;2023-10-03

3. Basic mechanisms of multisystemic inflammatory syndrome and severe acute respiratory syndrome coronavirus 2;Multisystem Inflammatory Syndrome - Natural History;2023-09-21

4. Increased Salivary Cytokines and Nitric Oxide Levels in Behçet’s Disease: Interleukin-32, a Novel Player in Disease Prognosis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-03

5. Interleukin-32 as a biomarker in rheumatic diseases: A narrative review;Frontiers in Immunology;2023-02-15